Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Zarin, D. A.
* Articles by Marcus, S. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Zarin, D. A.
* Articles by Marcus, S. C.
Related Collections
* Attention Deficit Hyperactivity Disorder
Psychiatr Serv 49:171, February 1998
© 1998 American Psychiatric Association


Column

Datapoints: Treatment of Attention-Deficit Hyperactivity Disorder by Different Physician Specialties

Deborah A. Zarin, M.D. , Terri L. Tanielian, M.A., Ana P. Suarez, M.P.H. and Steven C. Marcus, M.A.


  Introduction

 
 TOP
 Introduction
 References
 
In recent years, increased national attention has been drawn to the diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD). Much of the attention has focused on the large variation in practice patterns found in community studies, with the assumption that most children with ADHD are treated by primary care providers (1). It is not known what proportion of children treated for ADHD are cared for by psychiatrists or to what extent quality-of-care concerns raised by these community studies apply to the care provided by psychiatrists.

This column examines office visits for ADHD by patients age 14 or younger across physician specialties, including psychiatry. It uses weighted data from the 1995 National Ambulatory Medical Care Survey (NAMCS). ADHD-related office visits were identified by one of the following criteria: the International Classification of Diseases (ICD) code for ADHD listed in one of the diagnosis fields; at least one psychostimulant prescribed, supplied, administered, or continued during the visit; or a marked checkbox indicating an ADHD diagnosis.

A total of 3,423,089 ADHD-related visits were identified in 1995, representing 3.2 percent of all physician visits by patients age 14 or younger. Comparison with 1985 NAMCS data showed a fivefold increase in the number of ADHD-related visits between the two surveys. This increase may be partly attributed to the ADHD checkbox item, which was not included in the 1985 survey. However, disregarding this criterion, ADHD-related visits tripled between 1985 and 1995 (2). A psychostimulant was reported in 49 percent of the visits in 1995.

Figure 1 shows the distribution of the ADHD-related visits in 1995 for three physician specialties: primary care (general and family practice, adolescent medicine, pediatrics, geriatric medicine and internal medicine); psychiatry (child and adolescent psychiatry, psychiatry, and psychoanalysis); and other medical specialties, including neurology and child neurology. Visits to psychiatrists accounted for 12.4 percent of all ADHD-related visits, indicating that psychiatrists treat a substantial proportion of the childhood ADHD population. Some evidence suggests that the patients treated by psychiatrists constitute a more complex and more severely ill segment of the ADHD population (3). Therefore, it will be important to characterize the differences in patients seen by psychiatrists and primary care physicians as well as in the treatments they provide. In particular, efforts to improve the quality of care for children and adolescents with ADHD will need to take into account important differences in case mix and practice patterns.



View larger version (106K):
[in this window]
[in a new window]
 

Figure 1.  Office-based visits to physicians for attention-deficit hyperactivity disorder in 1995 (weighted N=3,423,089), by physician category




  Acknowledgments

 
The authors thank Julie Magno Zito, Ph.D., Harold Alan Pincus, M.D., Mark Olfson, M.D., M.P.H., and James Thompson, M.D., for their contributions to the analyses on which this report is based. This work was supported in part by a grant from the van Ameringen Foundation.


  Footnotes

 
Dr. Zarin, Ms. Tanielian, and Ms. Suarez are associated with the office of research of the American Psychiatric Association, 1400 K Street, N.W., Washington, D.C. 20005. Mr. Marcus is with the Stanley Center at Western Psychiatric Institute and Clinic in Pittsburgh. Ms. Tanielian and Harold Alan Pincus, M.D., are coeditors of this column.


  References

 
 TOP
 Introduction
 References
 

  1. Wolraich ML, Lindgren S, Stromquist A: Stimulant medication use by primary care physicians in the treatment of attention-deficit hyperactivity disorder. Pediatrics 86:95-101, 1990[Abstract/Free Full Text]
  2. Pincus HA, Tanielian TL, Marcus SC, et al: Prescribing trends in psychotropic medication: primary care, psychiatry, and other medical specialties. JAMA, in press
  3. Epstein MA, Shaywitz SE, Shaywitz BA, et al: The boundaries of attention deficit disorder. Journal of Learning Disabilities 24:78-86, 1991



This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
B. D. Fulton, R. M. Scheffler, S. P. Hinshaw, P. Levine, S. Stone, T. T. Brown, and S. Modrek
National Variation of ADHD Diagnostic Prevalence and Medication Use: Health Care Providers and Education Policies
Psychiatr Serv, August 1, 2009; 60(8): 1075 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
S. dosReis, P. L. Owens, K. B. Puccia, and P. J. Leaf
Multimodal Treatment for ADHD Among Youths in Three Medicaid Subgroups: Disabled, Foster Care, and Low Income
Psychiatr Serv, September 1, 2004; 55(9): 1041 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
A. Martin and D. Leslie
Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000
Arch Pediatr Adolesc Med, October 1, 2003; 157(10): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
A. Martin, T. Van Hoof, D. Stubbe, T. Sherwin, and L. Scahill
Multiple Psychotropic Pharmacotherapy Among Child and Adolescent Enrollees in Connecticut Medicaid Managed Care
Psychiatr Serv, January 1, 2003; 54(1): 72 - 77.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. J. Safer and M. Malever
Stimulant Treatment in Maryland Public Schools
Pediatrics, September 1, 2000; 106(3): 533 - 539.
[Abstract] [Full Text]


Home page
Arch Pediatr Adolesc MedHome page
J. M. Zito, D. J. Safer, S. dosReis, L. S. Magder, J. F. Gardner, and D. A. Zarin
Psychotherapeutic Medication Patterns for Youths With Attention-Deficit/Hyperactivity Disorder
Arch Pediatr Adolesc Med, December 1, 1999; 153(12): 1257 - 1263.
[Abstract] [Full Text] [PDF]


This Article
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Zarin, D. A.
* Articles by Marcus, S. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Zarin, D. A.
* Articles by Marcus, S. C.
Related Collections
* Attention Deficit Hyperactivity Disorder


Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org